ArticleGlobal cardiology science & practice2025
Puzzling obstructive tumor in the right heart: A large intravascular leiomyomatosis with intracardiac extension.
Article in Global cardiology science & practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidisciplinary management of intracardiac tumor thrombus in low-grade endometrial stromal sarcoma: case report and literature review.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIntravascular leiomyomatosis (IVL) is a rare benign tumor capable of hematogenous spread. Clinical presentation is heterogeneous depending on the destination organ, which often delays identification. Key steps: A 38-year-old female with a recent history of hysterectomy presented with dyspnea and dizziness. Initial workup revealed a huge obstructive growth in the right heart chambers. A thrombus-in-transit was the most likely preliminary diagnosis. Further thorough assessment reduced the likelihood of a thrombus and increased suspicion of a benign tumor. A large IVL with intracardiac extension was then considered. The mass was completely resected through a combined one-stage approach, and IVL was confirmed pathologically. The patient was well-educated about the importance of periodic surveillance for the reported high recurrence rates. What we have learned? IVL is a rare benign tumor that behaves like malignancy and, hence may have nonspecific presentations. Thorough clinical evaluation and collaborated multi-modality imaging are critical keys to the appropriate diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.